NanoViricides Announces Completion of $10.2 Million Registered Direct Offering – Funds to Accelerate COVID-19 Drug Program and HerpeCideā¢ Program
SHELTON, CT / ACCESSWIRE / May 26, 2020 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a leader in the development...